CC
NUVA

Curian Capital’s NuVasive, Inc. NUVA Stock Holding History

Curian Capital’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-6,529
Closed -$353K – 403
2015
Q4 		$353K Sell
6,529
-10,466
-62% -$534K 0.03% 349
2015
Q3 		$819K Sell
16,995
-6,847
-29% -$354K 0.02% 405
2015
Q2 		$1.13M Buy
23,842
+99
+0.4% +$4.63K 0.02% 441
2015
Q1 		$1.09M Buy
23,743
+385
+2% +$17.9K 0.02% 448
2014
Q4 		$1.1M Buy
23,358
+611
+3% +$25.5K 0.02% 426
2014
Q3 		$793K Buy
+22,747
New +$810K 0.01% 479

Other funds holding NUVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Curian Capital's NUVA Position: Q1 2016 in Review

Curian Capital sold out of NuVasive, Inc. (NUVA) in Q1 2016, closing a stake of 6,529 shares — an estimated $353K sold.

Curian Capital first reported a position in NUVA in Q3 2014 and held it in 6 quarters. The position peaked at $1.13M in Q2 2015. 249 funds tracked by Wall St. Rank hold NUVA as of Q1 2016.

  • Curian Capital reported no remaining NuVasive, Inc. position as of Q1 2016 after selling out during the quarter.
  • Curian Capital sold 6,529 NuVasive, Inc. shares in Q1 2016, an estimated $353K.
  • Curian Capital first reported a position in NuVasive, Inc. in Q3 2014 and held it in 6 quarters.
  • Curian Capital's NuVasive, Inc. position peaked at $1.13M in Q2 2015.
  • 249 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2016.

Based on Curian Capital's 13F filing for Q1 2016.